Breaking News on Drug DiscoveryDaily
Monday 30 July 2007
Forward to a colleague |
|
|
| Breaking News on Drug Discovery |
||
|
||
| Daily
Monday 30 July 2007 |
Forward to a colleague |
|
|
Sponsored Message  Live cell-based assay with Bionas® 2500 analyzing systemBionas® 2500 measures multiple metabolic parameters simultaneously like acidification, oxygen consumption and adhesion of living cells. Metabolic and cytotoxic effects can be visualized as changes of these parameters in dependence of test compounds... Click Here Access Full Stories  GlaxoSmithKline inks $1.5bn deal with TargaceptGlaxoSmithKline (GSK) has forged a $1.5bn (€1.1bn) alliance with US biopharma company Targacept, to develop drugs aimed at central nervous system (CNS) related disorders... Read AZ and BMS job cuts add to big pharma woes As pharma firms disclose their financial results for the second quarter of the year, AstraZeneca (AZ) and Bristol-Myers Squibb (BMS) have announced more job cuts... Read Aperio helps speed up tissue microarray analysis Aperio has released a new software tool that not only speeds up the analysis of tissue microarray (TMA) images but also allows researchers to access images remotely... Read UK ordered to review animal testing approval system The UK government has been ordered to review the assessment system it uses to classify and grant permission for animal experiments following a court ruling handed down last week... Read Drugs moving into the clinic: 22 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read |
|
||||||||
All News Headlines for: July | June | May |
||||||||||
 Sponsored MessageUser friendly newsfeed solutions Decision News Media is one of the world's most respected business to business publishers. Achieve optimal content dissemination using our multiple delivery options: RSS, XML feed, Web platform and email alerts... Click Here |
||||||||||
|
Related Industry News PRA to go private as Q2 profit tumbles PRA said it signed an agreement with equity firm Genstar Capital to be bought back by the firm for around $790m (€580m) while the CRO posted a 90 per cent tumble in profit in Q2 due to heavy restructuring... Read MorphoSys pleased with financial results German-based MorphoSys has a positive outlook for its antibody producing industry, despite the research antibody segment posting revenue 10 per cent below expectations in the six-month financial report released... Read Patent promise for oral insulin tablet tech A novel drug delivery technology capable of delivering large molecules in oral tablet form is set to gain patent protection in a number of countries through an international patent treaty... Read CRO market to reach $24bn by 2010 The total contract research organisation (CRO) market is expected to reach $24bn (€18bn) by 2010 as biopharma companies' spending on outsourcing services continues to soar, new research reveals... Read
|
||||||||||
|
|||
| Forward to a colleague |
|||
|
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
